You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
X
Recruiting
  • Leukemia, Myeloid, Acute
  • anti-CD33 CAR NK cells
  • +2 more
  • Chongqing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
2021-12-22
Dec 22, 2021
W
Active, not recruiting
  • Leukemia, Myeloid, Acute
  • New York, New York
    Weill Cornell Medical College
2021-12-10
Dec 10, 2021
X
Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Chongqing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
2021-08-20
Aug 20, 2021
M
Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Poznań, Poland
    Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medyczneg
2022-04-05
Apr 5, 2022
C
Recruiting
  • Leukemia
  • +2 more
  • CD123 CAR-T cells
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
2021-03-01
Mar 1, 2021
C
Recruiting
  • Leukemia
  • +2 more
  • CD123 CAR-T cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force
2021-03-01
Mar 1, 2021
Z
Recruiting
  • Leukemia, Myeloid, Acute
  • Guanzhou, Guandong, China
    Nanfang Hospital of Southern Medical University
2022-03-06
Mar 6, 2022
P
Recruiting
  • Leukemia, Lymphoblastic
  • Leukemia, Myeloid, Acute
  • This study is observational
  • Bauru, São Paulo, Brazil
    Faculdade de Odontologia de Bauru, Universidade de São Paulo
2021-07-08
Jul 8, 2021
N
Recruiting
  • Acute Myeloid Leukemia
  • Taipei, Taiwan
    National Taiwan University Hospital
2021-10-27
Oct 27, 2021
M
Completed
  • Leukemia, Myeloid, Acute
  • Liposomal Annamycin
  • La Jolla, California
  • +3 more
2022-02-28
Feb 28, 2022
P
Withdrawn
  • Leukemia, Myeloid, Acute
  • (no location specified)
2021-02-16
Feb 16, 2021
A
Enrolling by invitation
  • Leukemia, Myeloid, Acute
  • +2 more
  • observation only
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-03-29
Mar 29, 2021
T
Completed
  • Acute Myeloid Leukemia, Relapsed, Adult
  • CDIAG regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
2022-03-16
Mar 16, 2022
L
Completed
  • Leukemia, Myelogenous, Acute
    • Charlotte, North Carolina
      Levine Cancer Institute
    2021-11-05
    Nov 5, 2021
    U
    Recruiting
    • Leukemia, Myeloid, Acute
    • Minimal Residual Disease
      • Chapel Hill, North Carolina
        North Carolina Cancer Hospital (NCCH)
      2021-06-08
      Jun 8, 2021
      M
      Recruiting
      • Leukemia, Myeloid, Acute
      • Milwaukee, Wisconsin
        Froedtert Hospital
      2021-05-24
      May 24, 2021
      U
      Active, not recruiting
      • Acute Myeloid Leukemia
      • Behavioral: UR-GOAL communication tool
      • Rochester, New York
        University of Rochester Medical Center
      2022-03-15
      Mar 15, 2022
      P
      Completed
      • Leukemia, Myeloid, Acute
      • Gemtuzumab Ozogamicin
      • New York, New York
        Pfizer Investigational Site
      2021-07-16
      Jul 16, 2021
      G
      Recruiting
      • Acute Myeloid Leukemia
      • NanJing, China
        Department of Hematology, Zhongda Hospital, Medical School of So
      2022-03-22
      Mar 22, 2022
      U
      Recruiting
      • Acute Myeloid Leukemia
      • Aurora, Colorado
        Universtiy of Colorado Hospital
      2022-02-15
      Feb 15, 2022
      H
      Recruiting
      • Leukemia, Myeloid
      • Demonstration of T cell responses
      • Pierre-Bénite, France
        Hôpital Lyon Sud
      2021-07-26
      Jul 26, 2021
      M
      Available
      • Acute Myeloid Leukemia
      • +2 more
      • flotetuzumab
      • (no location specified)
      2021-08-18
      Aug 18, 2021
      U
      Suspended
      • Acute Myeloid Leukemia
      • Integrative Therapy
      • Gainesville, Florida
        University of Florida
      2022-01-14
      Jan 14, 2022